HIGHLIGHTS
- who: Tae Hyung Kim et al. from the Departments of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea have published the research work: Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 20-04), in the Journal: Cancers 2022, x of /2022/
- what: This study investigated the clinical efficacy of SABR in patients with oligometastatic HCC. The results of this study showed that SABR for all metastatic lesions appeared to be an effective and safe treatment for oligometastatic HCC. In the present study, additional analysis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.